Search Results - tally+largent-milnes

6 Results Sort By:
Hearing the Invisible
This is an immersive art experience in which individuals will walk through a model of a brain while using augmented reality (AR) for a more realistic, immersive experience. Attendees also listen to sonified electroencephalograms (EEGs) of healthy brains and brains with different diseases, such as dementia and Alzheimer’s which allows them to hear...
Published: 4/17/2025   |   Inventor(s): Tally Milnes, Cynthia Stokes, Michael Vince, Matthew Flowers, Brian McElroy
Keywords(s):  
Category(s): Technology Classifications > Creative Works, Technology Classifications > Healthcare Portfolios > Neurology
Augmented Reality App for Audible EEG
This is an augmented reality app for use with the Hearing the Invisible immersive experience in which attendees listen to audio versions of electroencephalograms (EEGs) to hear the difference between healthy brains and brains with different diseases, such as dementia and Alzheimer’s. QR codes throughout the experience link to the app, which has...
Published: 4/17/2025   |   Inventor(s): Tally Milnes, Michael Vince, Brian McElroy, Cynthia Stokes, Matthew Flowers
Keywords(s):  
Category(s): Technology Classifications > Creative Works, Technology Classifications > Healthcare Portfolios > Neurology, Technology Classifications > Software & Information Technology > Mobile Application
Hearing the Invisible Original Composition
This is a live performance of an original composition created for the Hearing the Invisible immersive art experience using electroencephalograms (EEGs) as a base for the audio. It includes original vocal and electronic musical composition. Background: Music and/or other audio sounds can augment immersive art experiences. They can be original compositions,...
Published: 4/17/2025   |   Inventor(s): Tally Milnes, Michael Vince, Cynthia Stokes, Matthew Flowers
Keywords(s):  
Category(s): Technology Classifications > Creative Works, Technology Classifications > Healthcare Portfolios > Neurology
Using the Serum Phosphoproteome of Migraine Patients as a Theragnostic
Biomarkers for neurological disease are lacking. Preliminary data, using an in vitro model of the blood brain barrier has suggested that serum release of tight junction proteins and the associated phosphoproteome may have utility as a biomarker for headache presence (diagnostic), such as migraine, and in therapeutic effect (theragnostic). This invention...
Published: 1/23/2024   |   Inventor(s): Tally Largent-Milnes, Jared Wahl
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios
Targeting 2AG Degradation for Headache
2-arachydonyl glycerol (2-AG) is a known endocannabinoid and a precursor compound for the generation of inflammatory mediators such as prostaglandins (PGs). This technology will enhance 2-AG levels and reduce PGs inhibiting enzymatic degradation. Several known compounds that work as inhibitors have been tested against the MAGL and ABHD6. The inventors...
Published: 11/16/2023   |   Inventor(s): Tally Largent-Milnes, Erika Liktor-Busa, Todd Vanderah, Nephi Stella
Keywords(s):  
Category(s): Technology Classifications > Life Sciences > Therapeutics
Targeted Therapy for Itch
TMEM184B is a relatively uncharacterized 7-pass transmembrane protein that is a member of the Transporter-Opsin-GPCR (TOG) superfamily of proteins. It was discovered that over-expression of TMEM184B caused a reduction in scratching in response to interleukin-31 (Il-31) exposure. This was surprising given previous studies had shown that knock-out of...
Published: 3/12/2024   |   Inventor(s): Martha Bhattacharya, Tally Largent-Milnes
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Neurology > CNS & Neurosciences, Technology Classifications > Healthcare Portfolios > Dermatology, Technology Classifications > Life Sciences > Therapeutics